Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-26T09:57:42.574Z Has data issue: false hasContentIssue false

Voluntary and involuntary admissions with schizoaffective disorder: do they differ from schizophrenia?

Published online by Cambridge University Press:  04 December 2020

A. Feeney*
Affiliation:
Department of Psychiatry, Trinity College Dublin, Trinity Centre for Health Sciences, Tallaght University Hospital, Dublin 24, Ireland
E. Umama-Agada
Affiliation:
Longford/Westmeath Mental Health Services, Mullingar, Co. Westmeath, Ireland
A. Curley
Affiliation:
Cavan Monaghan Mental Health Service, St. Davnet’s Complex, Co. Monaghan, Ireland
C. Anamdi
Affiliation:
Dublin North City and County Mental Health Services, St. Vincent’s Hospital, Fairview, Dublin 3, Ireland
M. Asghar
Affiliation:
South Kerry Mental Health Service, University Hospital Kerry, Co. Kerry, Ireland
B. D. Kelly
Affiliation:
Department of Psychiatry, Trinity College Dublin, Trinity Centre for Health Sciences, Tallaght University Hospital, Dublin 24, Ireland
*
*Address for correspondence: Dr A. Feeney, Department of Psychiatry, Trinity College Dublin, Trinity Centre for Health Sciences, Tallaght University Hospital, Dublin 24, D24 NR0A, Ireland. (Email: [email protected])
Rights & Permissions [Opens in a new window]

Abstract

Objectives:

Schizoaffective disorder and schizophrenia are common presentations to psychiatry services. Research to date has focussed on hypothesised biological differences between these two disorders. Little is known about possible variations in admission patterns. Our study compared demographic and clinical features of patients admitted voluntarily and involuntarily with diagnoses of schizoaffective disorder or schizophrenia to three psychiatry admission units in Ireland.

Methods:

We studied all admissions to three acute psychiatry units in Ireland for periods between 1 January 2008 and 31 December 2018. We recorded demographic and clinical variables for all admissions. Voluntary and involuntary admissions of patients with schizoaffective disorder were compared to those with schizophrenia.

Results:

We studied 5581 admissions to the study units for varying periods between January 2008 and December 2018, covering a total of 1 976 154 person-years across the 3 catchment areas. The 3 study areas had 218.8, 145.5 and 411.2 admissions per 100 000 person-years, respectively. Of the 5581 admissions over the study periods, schizoaffective disorder accounted for 5% (n = 260) and schizophrenia for 17% (n = 949). Admissions with schizoaffective disorder were significantly more likely to be female and older, and less likely to have involuntary admission status, compared to those with schizophrenia. As first admissions were not distinguished from re-admissions in this dataset, these findings merit further study.

Conclusions:

Admissions with a schizoaffective disorder differ significantly from those with schizophrenia, being, in particular, less likely to be involuntary admissions. This suggests that psychotic symptoms might be a stronger driver of involuntary psychiatry admission than affective symptoms.

Type
Original Research
Copyright
© The Author(s), 2020. Published by Cambridge University Press on behalf of The College of Psychiatrists of Ireland

Introduction

Schizoaffective disorder and schizophrenia are common presentations to psychiatry services and exert great personal, societal and health care costs. These disorders are often studied as a single group, so little is known about variations in admission patterns between them. Greater understanding of how these patients interact with inpatient mental health services would help tailor care offered to these patients. Schizoaffective disorder, in particular, is a very understudied condition in this regard.

In terms of morbidity, it is known that schizophrenia and related disorders can lead to a significant decline in functioning, with 1.7% the of total global years of life lived with disability attributable to schizophrenia (Charlson et al. Reference Charlson2018). Schizophrenia is ranked the 12th most disabling disorder globally (Vos et al. Reference Vos2017), with this burden falling most heavily on low and middle-income countries (Charlson et al. Reference Charlson2018). Schizophrenia is estimated to have a lifetime prevalence of 0.87% (Perälä et al. Reference Perälä2007), with no apparent difference in prevalence between men and women (Saha et al. Reference Saha2005; Perälä et al. Reference Perälä2007; Charlson et al. Reference Charlson2018). The incidence, however, is estimated at 15.2 per 100 000 per annum, with a male-to-female incident rate ratio of 1.40 (McGrath et al. Reference McGrath2004). Higher rates are seen in urban and migrant populations.

By contrast, the lifetime prevalence of schizoaffective disorder is estimated at 0.32%, with prevalence being higher amongst women than men (0.47% v. 0.14%) (Perälä et al. Reference Perälä2007). Identifying a reliable estimate of the incidence of schizoaffective disorder is complicated by frequent changes in its classification in diagnostic manuals over time.

The concept of a disorder with features typical of both schizophrenia and a mood disorder was first described by Kasanin in Reference Kasanin1933. He described these patients as having brief periods of psychotic symptoms, good recovery and better pre-morbid functioning compared to patients with schizophrenia (Kasanin Reference Kasanin1933). Schizoaffective disorder has been classified with psychotic illnesses rather than affective disorders in both the International Classification of Diseases (World Health Organization 1992) and the Diagnostic and Statistical Manual (American Psychiatric Association 2000).

Increasingly, however, there are concerns about the reliability of clinical diagnoses of schizoaffective disorder and its possible overuse in clinical practice. Significant differences are seen between research and clinical diagnoses (Wilson et al. Reference Wilson, Nian and Heckers2014) and inter-rater reliability for the diagnosis of schizoaffective disorder is poor compared to other psychiatric disorders (Maj et al. Reference Maj2000). There is also continued debate about whether schizoaffective disorder, schizophrenia, psychotic mood disorders and bipolar illness represent separate disorders or a continuum (Taylor & Amir Reference Taylor and Amir1994; Möller Reference Möller2003; Lake & Hurwitz Reference Lake and Hurwitz2006; Abrams et al. Reference Abrams, Rojas and Arciniegas2008), with some concluding that all these diagnoses should be viewed as a psychotic mood disorder, with a spectrum of severity of symptoms (Lake & Hurwitz Reference Lake and Hurwitz2006).

Genetic studies suggest a shared genetic risk between schizoaffective disorder, schizophrenia and mania (Cardno & Owen Reference Cardno and Owen2014). Genetic overlap is also seen between schizophrenia and bipolar disorder, although genetic loci differentiating these disorders are similarly identified (Ruderfer et al. Reference Ruderfer2018). Some research suggests a genetic distinction between a more severe psychosis subgroup, with lower levels of functioning, and a higher functioning subgroup with mixed bipolar and schizophrenia diagnoses (Dwyer et al. Reference Dwyer2020). Measuring neurocognitive and perceptual function might better classify patients with schizoaffective disorder, schizophrenia and bipolar disorder into distinct groups, compared to the current diagnostic classification systems (Clementz et al. Reference Clementz2016). Brain imaging does not appear to help differentiate these diagnostic groups either. Grey matter volume across brain regions differ when comparing patients with schizoaffective disorder and schizophrenia to healthy controls, but the two disorders are statistically indistinguishable when compared to each other (Clementz et al. Reference Clementz2016).

Much of the research in this area has focussed on identifying biological differences between patients with schizoaffective disorder and schizophrenia, and the diagnostic reliability of the two disorders. However, variations in admission trends and consequent resource implications are relatively under-researched. Our study seeks to compare the demographic and clinical features of patients admitted voluntarily and involuntarily with diagnoses of schizoaffective disorder or schizophrenia in three psychiatry admission units in Ireland over an 11-year period. In particular, we seek to examine whether the use of involuntary psychiatry admission differs between these two groups.

Materials and methods

Setting

We studied admissions to three acute psychiatry units in Dublin, Ireland (Tallaght University Hospital, Beaumont Hospital and the Mater Misericordiae University Hospital) for periods between 1 January 2008 and 31 December 2018, as part of the Dublin Involuntary Admission Study (DIAS). ‘Admissions’ were analysed as the unit of study and re-admissions of the same patients were not differentiated, that is a patient admitted three times over the study period was examined as three admissions. The acute psychiatry unit at the Tallaght University Hospital serves a catchment area of 273 419 people and has 52 inpatient beds (i.e., 19.0 beds per 100 000 population). The corresponding unit at the Beaumont Hospital serves 247 500 people and has 44 beds (17.8 beds per 100 000 population). The unit at the Mater Misericordiae University Hospital serves 32 869 people and has 10 beds (30.4 beds per 100 000 population). These bed numbers did not change over the study. Admissions to the Mater Misericordiae University Hospital spanned the full 11 years of data collection (1 January 2008–31 December 2018), while the other units were added after the study commenced. Data from the Tallaght University Hospital were collected from 1 January 2014 to 31 December 2018 (5 years) and data from the Beaumont Hospital were collected from 1 July 2014 to 30 June 2015 (1 year).

These units provide general adult and old age psychiatry inpatient services to urban and suburban populations. All three units are part of general hospitals and treat voluntary and involuntary patients, under the Ireland’s Mental Health Act 2001. Ireland’s public mental health service is arranged on a strict catchment area basis, such that all public (i.e., non-fee-paying) psychiatry admissions of individuals’ resident within the geographical catchment area of this service must occur in this admission unit.

In Ireland, involuntary admission and treatment of people with a mental disorder are governed by the Mental Health Act (Mental Health Act 2001), which has been fully operational since 2006. For a patient to be involuntarily admitted under this Act, they must have a ‘mental disorder’, as outlined in Section 3(1) of the legislation; that is, they must have a ‘mental illness’, ‘severe dementia’ or ‘significant intellectual disability’ where (a) ‘because of the illness, disability or dementia, there is a serious likelihood of the person concerned causing immediate and serious harm to himself or herself or to other persons’ (the ‘risk criterion’) or (b) ‘because of the severity of the illness, disability or dementia, the judgment of the person concerned is so impaired that failure to admit the person to an approved centre would be likely to lead to a serious deterioration in his or her condition or would prevent the administration of appropriate treatment that could be given only by such admission’, and ‘the reception, detention and treatment of the person concerned in an approved centre would be likely to benefit or alleviate the condition of that person to a material extent’ (the ‘treatment criterion’) or (c) both (a) and (b).

The involuntary admission process can be instigated by a (a) spouse, civil partner or relative; (b) authorised (designated) officer of the health service; (c) member of the police force; or (d) member of the public (subject to certain conditions). An ‘application’ is made to a general practitioner or other doctors who can then make a ‘recommendation’ that a patient be admitted to the hospital for assessment by a consultant psychiatrist. Within 24 hours of such an admission, the consultant psychiatrist must make a decision as to whether that person will be involuntarily admitted or not. The admission decision is subject to review by a mental health tribunal within 21 days.

Alternatively, a person who already is a voluntary inpatient in an inpatient psychiatry unit and expresses a desire to leave can be retained by a nurse or doctor for up to 24 hours if they think the patient meets the criteria for involuntary care. Within this period, the patient is assessed by two consultant psychiatrists and a decision made about whether their status should change to involuntary; that is, whether or not the voluntary patient undergoes a change of status from voluntary to involuntary (rather than being involuntary from the outset).

Data collection

For all admissions, we recorded gender, date of birth, occupation, marital status, date of admission, date of discharge, legal status and clinical discharge diagnosis. We recorded diagnosis using the International Classification of Diseases (World Health Organization 1992) and created groups of related diagnoses. For patients whose status was involuntary for part or all of their admission, we recorded whether their status was involuntary from the outset or they underwent a change of status from voluntary to involuntary during their admission. We also recorded the dates that involuntary status was commenced and terminated, the legal criteria on which the involuntary order was made and the method by which it was terminated, categorised as follows: (a) involuntary admission order revoked by responsible consultant psychiatrist; (b) involuntary admission order revoked by mental health tribunal; (c) involuntary admission order expired and not renewed; or (d) patient transferred to another hospital while still an involuntary patient.

Statistical analysis

We stored and analysed data using IBM SPSS Statistics (version 26). Data were normally distributed except where specified otherwise. For bi-variable analysis, we used the Student’s t-test and Pearson’s Chi-square test as appropriate. For multi-variable analysis, we performed two binary logistic regression analyses with diagnosis (schizoaffective disorder or schizophrenia) at the dependent variable. Independent variables were the variables that differed significantly between the two diagnostic groups on bi-variable testing. One regression model was for all patients (voluntary and involuntary) with schizoaffective disorder or schizophrenia and one regression model was for involuntary patients only.

Ethical approval

This study was approved by the research ethics committees of the Tallaght University Hospital, Beaumont Hospital and the Mater Misericordiae University Hospital, and was performed in accordance with the Declaration of Helsinki. This was a study of usual practice using existing routine data to evaluate the current mental health service. Data protection legislation was adhered to and the patient confidentiality was protected at all times. Data were stored on a password-protected research computer in a locked research office. Data were irrevocably anonymised and encrypted.

Results

During the study periods, there were 5581 admissions, of which 4723 (84.7%) were voluntary and 856 (15.3%) involuntary. Data collected in Tallaght University Hospital over 5 years spanned 1 367 095 person-years and there were 218.8 admissions per 100 000 person-years. Data collected in Beaumont Hospital over 1 year spanned 247 500 person-years, with 145.5 admissions per 100 000 person-years. Finally, data collected in the Mater Misericordiae University Hospital over 11 years spanned 361 559 person-years, with 411.2 admissions per 100 000 person-years.

Affective disorders were the most common diagnoses amongst all admissions (n = 1671, 30.0%), followed by psychotic disorders (n = 1464, 26.3%), personality disorders (n = 673, 12.1%), drug use disorders (n = 511, 9.2%), neurotic disorders (n = 506, 9.1%), other disorders (n = 433, 7.8%), alcohol disorders (n = 270, 4.8%) and organic disorders (n = 51, 0.9%). Schizoaffective disorder accounted for 4.7% (n = 260) of all admissions, schizophrenia 17.0% (n = 949) and other psychotic disorders 4.6% (n = 255) (Table 1). The proportions of admissions with schizophrenia and schizoaffective disorder to the Tallaght University Hospital, Beaumont Hospital and Mater Misericordiae University Hospital were broadly similar (schizophrenia 17.7%, 22.5% and 15.2%; schizoaffective disorder 5.0%, 5.8% and 4.0%, respectively). The proportions of schizophrenia versus schizoaffective disorder did not differ significantly between the three hospitals (Pearson’s Chi-square =0.237, p = 0.888).

Table 1. Diagnosis and legal admission status of psychiatry admissions in three Dublin psychiatry units over the study periods

On bi-variable testing, compared to admissions with schizophrenia, admissions with a schizoaffective disorder were more commonly female (63.8% v. 29.6%), older (mean age 44.16 years v. 39.13 years) and married (14.7% v. 7.7%), and less likely to be unemployed (69.5% v. 79.3%) (p < 0.001 in all cases; Table 2) or have an involuntary status for all or part of their admission (23.8% v. 37.6%; Pearson’s Chi-square = 17.094, p < 0.001). On multi-variable testing of all admissions (voluntary and involuntary), a diagnosis of the schizoaffective disorder rather than schizophrenia was significantly associated with female gender, voluntary status and older age (Table 3).

Table 2. Comparison of admissions (voluntary and involuntary) with schizoaffective disorder and schizophrenia in three Dublin psychiatry units over the study periods

S.D., Standard deviation.

Table 3. Binary logistic regression analysis of correlates of diagnosis amongst admissions (voluntary and involuntary) with schizoaffective disorder and schizophrenia in three Dublin psychiatry units over the study periods

In this binary logistic regression model, the dependent variable was diagnosis (schizoaffective disorder or schizophrenia); the independent variables were variables that differed significantly between the two diagnostic groups on bi-variable testing.

On bi-variable testing of involuntary admissions with schizoaffective disorder or schizophrenia, those with schizoaffective disorder (n = 62) were more likely to be female (53.2% v. 26.1%; p < 0.001) and older (mean age 46.84 v. 37.37 years; p < 0.001), and less likely to be unemployed (72.1% v. 81.7%; p = 0.010) compared to those with schizophrenia (n = 357) (Table 4). Involuntary admissions with schizoaffective disorder did not differ significantly from those with schizophrenia in relation to the legal criteria upon which involuntary admission was based, duration of overall admission, duration of time spent with involuntary status or method by which involuntary admission ended. On multi-variable testing of involuntary admissions, a diagnosis of the schizoaffective disorder rather than schizophrenia was significantly associated with older age and female gender (Table 5).

Table 4. Comparison of involuntary admissions with schizoaffective disorder and schizophrenia in three Dublin psychiatry units over the study periods

S.D., Standard deviation.

Table 5. Binary logistic regression analysis of correlates of diagnosis amongst involuntary admissions with schizoaffective disorder and schizophrenia in three Dublin psychiatry units over the study periods

In this binary logistic regression model, the dependent variable was diagnosis (schizoaffective disorder or schizophrenia); the independent variables were the variables that differed significantly between the two diagnostic groups on bi-variable testing.

Discussion

We found that affective disorders were the most common diagnoses amongst voluntary admissions and psychotic disorders were most common amongst involuntary admissions. This is in keeping with previous studies, which have found an association between psychosis and involuntary admission status (Riecher et al. Reference Riecher1991; Salize & Dressing Reference Salize and Dressing2004) and is also consistent with prior reports from the DIAS (Ng & Kelly Reference Ng and Kelly2012; Curley et al. Reference Curley2016; Umama-Agada et al. Reference Umama-Agada2018; Feeney et al. Reference Feeney2019). In interpreting our findings of differences between admissions with schizophrenia and schizoaffective disorder, it should again be noted that first admissions were not distinguished from re-admissions in this dataset. It is possible that individuals with a high number of re-admissions could have driven statistically significant findings.

Compared to admissions with schizophrenia, admissions with a schizoaffective disorder were more likely to be female (63.8% v. 29.6%), which is consistent with previous literature (Perälä et al. Reference Perälä2007). Admissions with a schizoaffective disorder were also older than those with schizophrenia on both bi-variable and multi-variable testing (mean age 44.16 years v. 39.13 years). Bi-variable testing indicated that admissions with a schizoaffective disorder were more likely to be married (14.7% v. 7.7%), and less likely to be unemployed (69.5% v. 79.3%) compared to those with schizophrenia, suggesting a better social function in schizoaffective disorder (Dwyer et al. Reference Dwyer2020), but these associations were not apparent on multi-variable testing and are therefore not considered further.

Most significantly, we found a difference between the two diagnostic groups in terms of involuntary admission, as significantly fewer admissions with the schizoaffective disorder had involuntary status compared to those with schizophrenia (23.8% v. 37.6%). This suggests that psychotic symptoms might be a stronger driver of involuntary admission than affective symptoms. More specific features of involuntary admission did not differ between the two groups, such as legal criteria for admission, duration of admission, length of time spent as an involuntary patient or method by which involuntary status was revoked.

Our study has several strengths. We focused on a relatively understudied issue; that is, whether there are clinical differences in the ways that patients with schizoaffective disorder and schizophrenia present to, and are treated by, mental health services, especially in relation to specific parameters of psychiatry admission such legal status, duration of admission. We studied a broad range of variables, including gender, age, occupation, marital status, diagnosis, legal criteria for involuntary admission, duration of admission, duration of involuntary care and reason for termination of involuntary status. Our study spans more than a decade of admission data and examines over 5000 admissions.

Limitations include the facts that our research is based in urban and suburban centres in Ireland, which might reduce generalisability; re-admissions were not differentiated from first admissions; we recorded only one diagnosis per patient when some might have had two or more; factors relating to deprivation and social supports were not examined; type of schizoaffective episode (mood or psychotic episode) was not specified; and only data from one of the three units spanned the full study period, limiting potential comparisons. While we focused on comparing patients with schizoaffective disorder and schizophrenia, we did not examine patients with other psychotic disorders (e.g., depression, mania). Some of these other diagnoses might, in time, be revised to schizoaffective disorder or schizophrenia; a more detailed, longitudinal study would be needed to elucidate these issues. Furthermore, as described in the introduction, there are issues in reliably distinguishing schizophrenia from schizoaffective disorder and these should also be considered in interpreting our findings. We also did not examine admission diagnoses in the context of beds per capita. Future research could usefully examine the impact of variability in beds per capita between catchment areas on the diagnostic mix amongst admissions.

Overall, we found that admissions of patients with schizoaffective disorder differ in significant respects from those with schizophrenia. More specifically, admissions with schizoaffective disorder are more likely to be female and older, and less likely to have involuntary admission status, compared to those with schizophrenia. We hypothesise that psychotic symptoms might be a stronger driver of involuntary psychiatry admission than affective symptoms. However, future research examining the relationship between the type of schizoaffective episode and involuntary status is needed to further elucidate if such an association exists.

Acknowledgements

We are very grateful to everyone who assisted with this study.

Conflicts of interest

None.

Ethical standards

This study was approved by the research ethics committees of Tallaght University Hospital, Beaumont Hospital and the Mater Misericordiae University Hospital. The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committee on human experimentation with the Helsinki Declaration of 1975, as revised in 2008.

Financial support

This research received no specific grant from any funding agency, commercial or not-for-profit sectors.

References

Abrams, DJ, Rojas, DC, Arciniegas, DB (2008). Is schizoaffective disorder a distinct categorical diagnosis? A critical review of the literature. Neuropsychiatric Disease and Treatment 4, 10891109. doi: 10.2147/ndt.s4120.CrossRefGoogle ScholarPubMed
American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. American Psychiatric Association: Washington, DC.Google Scholar
Cardno, AG, Owen, MJ (2014). Genetic relationships between schizophrenia, bipolar disorder, and schizoaffective disorder. Schizophrenia Bulletin 40, 504515. doi: 10.1093/schbul/sbu016.CrossRefGoogle ScholarPubMed
Charlson, FJ, et al. (2018). Global epidemiology and burden of schizophrenia: findings from the global burden of disease study 2016. Schizophrenia Bulletin 44, 11951203. doi: 10.1093/schbul/sby058.CrossRefGoogle ScholarPubMed
Clementz, BA, et al. (2016). Identification of distinct psychosis biotypes using brain-based biomarkers. American Journal of Psychiatry. American Psychiatric Association 173, 373384. doi: 10.1176/appi.ajp.2015.14091200.CrossRefGoogle Scholar
Curley, A, et al. (2016). Exploring and explaining involuntary care: the relationship between psychiatric admission status, gender and other demographic and clinical variables. International Journal of Law and Psychiatry 47, 5359. doi: 10.1016/j.ijlp.2016.02.034.CrossRefGoogle ScholarPubMed
Dwyer, DB, et al. (2020). An investigation of psychosis subgroups with prognostic validation and exploration of genetic underpinnings: the PsyCourse study. JAMA Psychiatry. doi: 10.1001/jamapsychiatry.2019.4910.CrossRefGoogle ScholarPubMed
Feeney, A, et al. (2019). Gender, diagnosis and involuntary psychiatry admission in Ireland: a report from the Dublin Involuntary Admission Study (DIAS). International Journal of Law and Psychiatry 66, 101472. doi: 10.1016/j.ijlp.2019.101472.CrossRefGoogle Scholar
Kasanin, J (1933). The acute schizoaffective psychoses. American Journal of Psychiatry 151 (Suppl. 6), 144154. doi: 10.1176/ajp.90.1.97.Google Scholar
Lake, CR, Hurwitz, N (2006). Schizoaffective disorders are psychotic mood disorders: there are no schizoaffective disorders. Psychiatry Research, 255287. doi: 10.1016/j.psychres.2005.08.012.CrossRefGoogle ScholarPubMed
Maj, M, et al. (2000). Reliability and validity of the DSM-IV diagnostic category of schizoaffective disorder: preliminary data. Journal of Affective Disorders 57, 9598. doi: 10.1016/S0165-0327(99)00059-2.CrossRefGoogle ScholarPubMed
McGrath, J, et al. (2004). A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Medicine, 13. doi: 10.1186/1741-7015-2-13.CrossRefGoogle ScholarPubMed
Möller, HJ (2003). Bipolar disorder and schizophrenia: distinct illnesses or a continuum? Journal of Clinical Psychiatry 64 (Suppl. 6), 2327.Google ScholarPubMed
Ng, XT, Kelly, BD (2012). Voluntary and involuntary care: three-year study of demographic and diagnostic admission statistics at an inner-city adult psychiatry unit. International Journal of Law and Psychiatry 35, 317326. doi: 10.1016/j.ijlp.2012.04.008.CrossRefGoogle ScholarPubMed
Perälä, J, et al. (2007) Lifetime prevalence of psychotic and bipolar I disorders in a general population. Archives of General Psychiatry 64, 1928. doi: 10.1001/archpsyc.64.1.19.CrossRefGoogle ScholarPubMed
Riecher, A, et al. (1991) Factors influencing compulsory admission of psychiatric patients. Psychological Medicine 21, 197208 (http://www.ncbi.nlm.nih.gov/pubmed/2047496). Accessed 24 January 2019.CrossRefGoogle ScholarPubMed
Ruderfer, DM, et al. (2018). Genomic dissection of bipolar disorder and schizophrenia, including 28 subphenotypes. Cell 173, 17051715.e16. doi: 10.1016/j.cell.2018.05.046.CrossRefGoogle Scholar
Saha, S, et al. (2005). A systematic review of the prevalence of schizophrenia. PLoS Medicine 2, e141. doi: 10.1371/journal.pmed.0020141.CrossRefGoogle ScholarPubMed
Salize, HJ, Dressing, H (2004). Epidemiology of involuntary placement of mentally ill people across the European Union. The British Journal of Psychiatry: The Journal of Mental Science 184, 163168 (http://www.ncbi.nlm.nih.gov/pubmed/14754830). Accessed 24 January 2019.CrossRefGoogle ScholarPubMed
Taylor, MA, Amir, N (1994). Are schizophrenia and affective disorder related? The problem of schizoaffective disorder and the discrimination of the psychoses by signs and symptoms. Comprehensive Psychiatry 35, 420429. doi: 10.1016/0010-440x(94)90224-0.CrossRefGoogle ScholarPubMed
Umama-Agada, E, et al. (2018). Variations in involuntary admission rates at three psychiatry centres in the Dublin Involuntary Admission Study (DIAS): can the differences be explained? International Journal of Law and Psychiatry 57, 1723. doi: 10.1016/j.ijlp.2017.12.007.CrossRefGoogle ScholarPubMed
Vos, T, et al. (2017). Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet 390, 12111259. doi: 10.1016/S0140-6736(17)32154-2.CrossRefGoogle Scholar
Wilson, JE, Nian, H, Heckers, S (2014). The schizoaffective disorder diagnosis: a conundrum in the clinical setting. European Archives of Psychiatry and Clinical Neuroscience 264, 2934. doi: 10.1007/s00406-013-0410-7.CrossRefGoogle ScholarPubMed
World Health Organization (1992). The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. World Health Organization: Geneva.Google Scholar
Figure 0

Table 1. Diagnosis and legal admission status of psychiatry admissions in three Dublin psychiatry units over the study periods

Figure 1

Table 2. Comparison of admissions (voluntary and involuntary) with schizoaffective disorder and schizophrenia in three Dublin psychiatry units over the study periods

Figure 2

Table 3. Binary logistic regression analysis of correlates of diagnosis amongst admissions (voluntary and involuntary) with schizoaffective disorder and schizophrenia in three Dublin psychiatry units over the study periods

Figure 3

Table 4. Comparison of involuntary admissions with schizoaffective disorder and schizophrenia in three Dublin psychiatry units over the study periods

Figure 4

Table 5. Binary logistic regression analysis of correlates of diagnosis amongst involuntary admissions with schizoaffective disorder and schizophrenia in three Dublin psychiatry units over the study periods